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Abstract
Background: Polyprenol is an important lipid with many bioactive effects. The study on differences in bioactive
effects of polyprenol derivatives having different isoprene units are seldom reported and it is helpful to find out
which type of polyprenol derivatives are effective for treating A549/HepG2 cells and E. coli /S. aureus.
Methods: All tested polyprenol derivatives were measured with inhibition halos by Oxford cup assays. MIC values
were assessed by the broth dilution method. Time-killing curve studies were conducted in duplicate on separate
days. Cytotoxicity study was measured by the MTT assay and genotoxic study was evaluated by comet assay.
Results: With regard to antibacterial activity, the sensitivities to the quaternary polyprenyl ammonium salt
derivatives GAS and MAS were 31.3 μg/mL and 15.6–31.3 μg/mL, respectively. GAS and MAS exhibited cytotoxic
activity toward HepG2 cells (IC50 of 10.1–11.6 μg/mL), which was stronger than that exhibited toward A549 cells
(IC50 of 13.8–13.9 μg/mL). The bactericidal activity of MAS was stronger than that of GAS at the same concentration
at least 48 h. The DNA damage in A549 and HepG2 cells exposed to all 10, 20 and 40 μg/mL MAS was statistically
significant in comparison to the control. Our results indicate a dose-dependent increment in DNA damage in A549
and HepG2 cells exposed to 10, 20 and 40 μg/mL MAS for both the percentage of DNA in the tail and tail moment.
Conclusion: The quaternary ammonium salt derivatives GAS and MAS exhibited higher antibacterial (E. coli and S.
aureus) and cytotoxic activity (A549 and HepG2 cells) than the other derivatives evaluated in this study. The DNA
damage in HepG2 cells suggests that MAS induced A549 and HepG2 cells death via apoptotic pathway. Our results
provide new evidence supporting the medical use of polyprenol derivatives against bacterial and tumor diseases.
Keywords: Polyprenol, Nitrogenated derivatives, Haloid derivatives, Antibacterial activity, Cytotoxic activity,
Genotoxic activity
Background
Ginkgo biloba (Ginkgoopsida, Ginkgoales, Ginkgoaceae,
Ginkgo bilobaL.) leaf polyprenol (GBP) and Morus alba
(Dicotyledoneae, Rosales, Moraceae, Morus L.) leaf poly-
prenol (MBP) are long-chain polyisoprenoid alcohols.
These molecules are typically composed of a number of
unsaturated isoprene units; they are a type of betulapre-
nol with an E, E-farnesyl residue at the ω-end of the
prenyl chain and are terminated by an isoprene unit
bearing a primary hydroxyl group. GBP generally con-
sists of 70 to 120 carbons [1], and MBP consists of 50 to
60 carbons [2]. Polyprenols have various medical func-
tions, such as antiviral [3], antitumor [4], hepatoprotec-
tive [5], anti-Alzheimer [6] and synergistic antibacterial
[1] activities. Indeed, the bioactivity of polyprenols to-
ward single-celled organisms and the cells of higher or-
ganisms in vitro has gradually become a focus of lipid
research. For example, one study determined that allo-
prenols, a newly discovered class of polyprenols in plants
that contain an α-isoprene unit in the trans-(E)-
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configuration, increase membrane permeability to a
greater extent than polyprenols with the more common
cis-configuration [7]. Further evidence suggests that an
increase in dolichol length can slightly enhance mem-
brane destabilization at earlier times [8]. Good antibac-
terial activity against both gram-negative and gram-
positive bacteria (MIC 6.25–25.0 mg/mL and MBC
12.50–25.0 mg/mL) has been demonstrated in vitro by
polyprenols isolated from the leaves of Kirganelia reticu-
late [9], and we previously reported MIC values of 31.3
μg/mL and MBC and MFC values of 125 μg/mL for
GBP (inhibition halos 13.4–13.8 mm) [1]. Thus, it can
be inferred that different polyprenols possess different
antibacterial activities. Moreover, different polyprenol
derivatives also show different antibacterial activities. In
fact, our recent study of five GBP derivatives—polypre-
nyl acetate (GPA), n-amyl polypentylene (GAP),
polyprenyl-3-isoamyl benzyl ether (GPB), polyprenyl
dichlorophosphite (GPD) and polyprenyl phosphate dis-
odium salt (GPP) - synthesized from GBPs (C70–C120)
suggested a decrease in the antibacterial/antifungal activ-
ities and synergistic effect of alkyl-substituted GBP de-
rivatives; however, an increase was observed with a
phosphate-substituted GBP derivative [10]. As phos-
phorylated polyprenols generally possess higher activity
than free polyprenols, studying polyprenyl and dolichyl
phosphate analogs modified at the anionic group is of
substantial interest, particularly with regard to compari-
sons of their biological activities [11].
Previously, it has been reported that amino derivatives
of linear isoprenoids possess immunomodulating, antiul-
cer, and antithrombotic properties [12], and prenylamines
demonstrate anti-vaccinia virus activity as well as human
interferon-inducing properties [13]. Veselovsky [14] devel-
oped a simple method for synthesizing polyprenyl amines
of polyprenols from mulberry leaves and pine needles via
a two-step transformation. Sizova11 synthesized a quater-
nary polyprenyl ammonium salt using mulberry leaf poly-
prenols with triethylamine in the presence of phosphorus
oxychloride, and cationic polyprenyl derivatives may be
useful for transfection and immunological studies. In the
present study, a microemulsion containing these nitroge-
nated and haloid polyprenol derivatives was investigated
and found to have antibacterial, cytotoxic and genotoxic
properties. The compounds tested are polyprenyl phthali-
mide derivatives (GPH from GBP and MPH from MBP),
polyprenyl amine derivatives (GAM from GBP and MAM
from MBP), quaternary polyprenyl ammonium salt deriva-
tives (GAS from GBP and MAS from MBP), polyprenyl
trifluoroacetate derivatives (GTF from GBP and MTF
from MBP) and polyprenyl chloroacetate derivatives
(GCH from GBP and MCH from MBP) of polyprenols of
two different chain lengths isolated from the leaves of
Ginkgo biloba (GBL) and Morus alba (MBL). The study
on differences in bioactive effects among polyprenol deriv-
atives having different isoprene units is seldom reported
and it could be helpful to find out which type of polypre-
nol derivatives are effective for treating A549/HepG2 cells
and E. coli/S. aureus. E. coli (Gram-negative bacteria) and
S. aureus (Gram positive bacteria) are the two most com-
mon and typical kinds of pathogenic bacteria. The study
on the antibacterial activities against E. coli and S. aureus
is representative and significant to treat bacterial contam-
ination and infection. Lung and liver cancer are two types
of cancer having a higher incidence in developing coun-
tries. A549 (from lung cancer cell) and HepG2 (from liver
cancer cell) cells are good objects for studying on treating
lung and liver cancer cells. Antibacterial, cytotoxic and
genotoxic activities of these derivatives of C50–C60 and
C70–C120 polyprenols have seldom been reported to date.
Results and discussion
Structural determination
The structures (Fig. 1) of GPH, MPH, GAM, MAM,
GAS, MAS, GTF, MTF, GCH and MCH were deter-
mined by 1H-NMR data reported in this paper and the
corresponding references [14].
Antibacterial activity
The antibacterial activities of GPH, MPH, GAM, MAM,
GAS, MAS, GTF, MTF, GCH and MCH against E. coli
and S. aureus were assessed at 500 μg/mL, and their po-
tency was quantitatively assessed based on inhibition
halos (Table 1) and MIC values (Table 2). Analysis of
variance (Tukey’s test at 5 % probability) indicated a sig-
nificant difference (p < 0.05) among all the samples.
Among the samples tested, the MIC values indicated
that the polyprenyl ammonium salt derivatives GAS and
MAS had the highest activity and inhibited the growth
of both bacteria. The MIC values for GAS and MAS
were 31.3 μg/mL and in the range of 15.6–31.3 μg/mL,
respectively. The inhibition halo diameters from large to
small were MAS, GAS, GTF ≈MAM, GAM ≈MTF,
GCH ≈GPH ≈MCH, MPH for E. coli and MAS, GAS,
GTF, MAM ≈MTF, GAM ≈GCH, MCH ≈GPH, MPH
for S. aureus. Most importantly, all samples were effect-
ive at inhibiting the growth of the two examined bac-
teria. Moreover, the same types of derivatives showed
different antibacterial activities, with those of the phtha-
limides, trifluoroacetate derivatives of GBP and chloroa-
cetate derivatives of GBP being higher than those of
MBP. Overall, the antibacterial activities of the amine
and quaternary ammonium salt derivatives of GBP were
lower than those of MBP. These results suggest that the
quaternary polyprenyl ammonium salt derivatives (GAS
and MAS) have higher antibacterial activity (E. coli and
S. aureus) compared with the other nitrogenated and
haloid polyprenol derivatives. We therefore next decided
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to examine time-killing curves for GAS and MAS at dif-
ferent concentration.
Time-killing curves of E. coli and S. aureus in GAS and
MAS at different concentration
The time-killing curves for E. coli and S. aureus treated
with GAS and MAS at different concentration (0.5, 1
and 2 times the MIC) are shown in Figs. 2 and 3.
Overall, the bactericidal activity of MAS was stronger
(Tukey’s test, p < 0.05) than that of GAS at the same
concentration at least 48 h (we did not test longer dura-
tions). 2 times the MIC concentration of GAS and MAS
treatment resulted in a rapid decline (decreasing at least
99.9 %, ≥ 3 × log) of initial population of E. coli and S.
aureus within 2 h. By contrast, 1 times the MIC concen-
tration of GAS and MAS were able to decrease 99.0 %
(≥2 × log) of E. coli and S. aureus population within 2 h.
0.5 and 2 times the MIC of GAS and MAS were stron-
gest antibacterial effect until them were treated for 8 h
while 1 times the MIC of GAS and MAS were strongest
antibacterial effect until them were treated for 10 h. 0.5
times the MIC of GAS were inactivated against E. coli
and S. aureus after 24 h.
An increasing number of studies have shown that
polymeric quaternary ammonium compounds exhibit
greater bactericidal activities than their precursor mono-
mers, which may be due by the antibacterial action of
quaternary ammonium salts [15, 16]. There are four
basic key factors in the antibacterial activity of polymeric
quaternary ammonium salts [17]: (1) adsorption onto
the negatively charged bacterial cell surface; (2) penetra-
tion of the cell wall; (3) binding to the plasma mem-
brane; and (4) damaging the plasma membrane. It is
considered that similar to the addition of polyprenyl
groups, the polymerization of monomers could increase
the positive charge density of the polymer coil, which
could further enhance the ability of a compound to effi-
ciently adsorb onto the negatively charged bacterial sur-
face. Therefore, increasing the number of polyprenyl
groups could help promote this process (1). Many re-
searchers have noted that the antibacterial activity of
small-molecule quaternary ammonium salts is regulated
by the long hydrophobic chain, which could affect the
plasma membrane [18, 19]. Consequently, steps (3) and
Fig. 1 Synthesis of the compounds. 1.GPH 2.MPH 3.GAM 4.MAM
5.GAS 6.MAS 7.GTF 8.MTF 9.GCH 10.MCH
Table 1 Comparison of the inhibition halos among different
samples (Tukey’s test at 5 % probability)
Samples Diameter of the inhibition halos (mm) ± SEM, n = 3
E. coli S. aureus
GPH 15.6 ± 0.3 a 16.0 ± 0.2 a
MPH 15.2 ± 0.3 b 15.1 ± 0.2 b
GAM 16.4 ± 0.3 c 16.8 ± 0.2 c
MAM 16.9 ± 0.3 d 17.2 ± 0.2 d
GAS 19.1 ± 0.3 e 19.8 ± 0.2 e
MAS 19.8 ± 0.3 f 20.9 ± 0.2 f
GTF 16.9 ± 0.3 d 17.5 ± 0.2 g
MTF 16.3 ± 0.3 c 17.1 ± 0.2 d
GCH 15.7 ± 0.3 a 16.7 ± 0.2 c
MCH 15.6 ± 0.3 a 16.1 ± 0.2 a
GS 24.1 ± 0.2 23.0 ± 0.3
The same lowercase letters in the column of the same group indicate no
statistical difference (Tukey’s HSD test, p > 0.05). GS Gentamycin sulfate
Table 2 Minimum inhibitory concentration (μg/mL) of different
samples
Samples MIC values (μg/mL)
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(4) could be enhanced by increasing the length of the
substituted alkyl chain (quaternary ammonium group).
It is possible that a polyprenol with a long hydrophobic
chain and several isopentyl groups, such as a quaternary
ammonium salt derivative, could bind more readily to
the plasma membrane, ultimately increasing damage.
Cytotoxic and genotoxic assay
Cytotoxicity toward two cell lines (A549 and HepG2)
was evaluated by MTT assay. The results (Table 3)
showed that both GAS and MAS exhibited cytotoxic ac-
tivity toward both cell lines, whereas GTF and MTF ex-
hibited cytotoxic activity toward only the HepG2 cell
line (IC50 of 33.1–39.8 μg/mL). The other compounds
were found to be inactive because their IC50 values were
greater than 50 μg/mL. In addition, MAS showed the
highest activity toward HepG2 cells, with an IC50 of
10.1 μg/mL. GAS and MAS both exhibited stronger
cytotoxic activity toward HepG2 (IC50 of 10.1–11.6 μg/
mL) compared with A549 (IC50 of 13.8–13.9 μg/mL)
cells. These results indicate that the quaternary polypre-
nyl ammonium salt derivatives (GAS and MAS) have
higher cytotoxic activity (A549 and HepG2 cells) than
the other nitrogenated and haloid polyprenol derivatives
tested. Moreover, the polyprenyl derivatives of the same
type but with different numbers of carbons (GAS with
MAS, GTF with MTF) exhibited significantly different
cytotoxic activities toward HepG2 cells. Subsequently,
the highest activity MAS treated tumor cells were fixed
and then examined by microscopy, with the results
shown in Fig. 4. In cells untreated with derivative (con-
trol) and the cells were well spread out. In contrast, the
Fig. 2 Time-killing curves for Escherichia coli treated with GAS and MAS at different concentration (Mean ± SD, n = 3)
Fig. 3 Time-killing curves for Staphylococcus aureus treated with GAS and MAS at different concentration (Mean ± SD, n = 3)
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MAS treated cells showed pronounced shrinkage with
much apoptotic debris. MAS caused more serious struc-
tural damage to both the A549 and HepG2 cells with
the increase of concentration of MAS. Relative inhibition
ratio (R%) of 20 μg/mL MAS treating A549 and HepG2
were 80.1 % and 91.1 %, respectively (Fig. 5). By contrast,
R% of 10 μg/mL MAS treating A549 and HepG2 were
38.2 % and 48.8 %, respectively.
Genotoxic study of A549 and HepG2 treated with
MAS was evaluated by comet assay. The results obtained
in the comet assay showed that the DNA damage in
A549 and HepG2 cells exposed to all 10, 20 and 40 μg/
mL MAS was statistically significant in comparison to
the control (Table 4). The induced genotoxicity in both
A549 and HepG2 cells followed a direct dose–response
effect with positive induction at 10, 20 and 40 μg/mL
doses of MAS for both the percentage of DNA in the tail
(% DNA tail) and tail moment (arbitrary units).
Many studies have shown that quaternary ammonium
salt derivatives have higher efficiency against tumor cells
compared with the original compounds. Giraud [20] re-
ported that quaternary ammonium salt derivatives con-
jugated with the melphalan alkylating agent showed
Table 3 Cytotoxic activity of different samples






GAS 13.9 ± 0.2 a 11.6 ± 0.3 a
MAS 13.8 ± 0.2 a 10.1 ± 0.3 b
GTF >50 39.8 ± 0.3 c




The same lowercase letters in the column of the same group indicate no
statistical difference (Tukey’s HSD test, p > 0.05). When IC50 > 50 μg/mL
denotes inactive cytotoxic activity. EP etoposide
Fig. 4 Microscopic images of A549 and HepG2 cells treated with MAS
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micromolar-range antiproliferative activity against Saos-
2 human osteosarcoma and HEMCSS human chondro-
sarcoma cells based on their ability to combine with pro-
teoglycans. Gil’s study [21] further suggested that
introducing cationic quaternary ammonium onto β-
cyclodextrin to confer nanoparticles with non-negative
zeta potential values increased the ability of the nanopar-
ticles to penetrate the endothelial cell monolayer of bo-
vine brain microvessels. The quaternary ammonium
groups of cationic lipids could be used for transfection
of various biologically active compounds (e.g., hor-
mones, peptides, nucleosides, polynucleotides) into cells
of both animal and plant origin [22]. Research on the
antitumor activity of cationic lipids revealed that the
presence of a quaternary ammonium group is crucial for
various biological activities, and there is growing interest
in chemical and biological studies of polyprenols and
corresponding derivatives related to the study of post-
translational protein prenylation. Accordingly, the low
toxicity of polyprenols when cultured with susceptible
cells prompted us to investigate possible ways in which
the synthesis of polyprenyl derivatives with positive
charges can be used in immunology [23]. Research on
the synthesis of secondary and tertiary polyprenylamines
has been reported [24], and these compounds showed
higher antitumor and antiviral activities compared with
the original compounds [25, 26].
Conclusions
In this study, nitrogenated and haloid derivatives of
C50–C60 and C70–C120 polyprenols were synthesized,
and the antibacterial activities against E. coli and S. aur-
eus, cytotoxic and genotoxic activities against A549 and
HepG2 cells were investigated. Overall, the quaternary
polyprenyl ammonium salt derivatives GAS and MAS
exhibited higher antibacterial (E. coli and S. aureus) and
cytotoxic activity (A549 and HepG2 cells) compared
with the other polyprenol derivatives evaluated. The
Fig. 5 Cell viability effects of MAS at different concentration in A549 and HepG2 cells using the MTT assay (Mean ± SD, n = 3)




% DNA tail Tail moment (arbitrary units)
A549 HepG2 A549 HepG2
MAS
10 31.03 ± 3.31* 35.58 ± 2.84* 34.73 ± 3.02* 36.78 ± 2.98*
20 57.99 ± 4.02* 59.92 ± 4.14* 54.87 ± 4.77* 57.45 ± 4.63*
40 69.49 ± 4.89* 73.95 ± 5.23* 69.06 ± 5.11* 74.21 ± 3.96*
Control 9.15 ± 1.21 9.49 ± 1.10 4.95 ± 0.95 5.12 ± 0.87
EP (0.5 μg/mL) 70.08 ± 4.33* 77.12 ± 4.01* 75.54 ± 3.86* 80.63 ± 4.55*
aMean ± standard error from 2 independent experiments; 100 cells were counted for each experiment
*P < 0.01 versus control using Student’s t-test
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DNA damage in HepG2 cells suggests that MAS in-
duced A549 and HepG2 cells death via apoptotic path-
way. This study provides new evidence supporting the




Dried GBL and MBL were collected in October 2014
from China’s Jiangsu Province. The plants were identi-
fied and authenticated by Prof. Cheng-Zhang Wang at
the Institute of Chemical Industry of Forestry Products,
CAF, China. Standard polyprenols (C50, C55, C60, C75–
C105, C110, C115, C120) were purchased from Larodan
Fine Chemical Co., Ltd, (Malmo, Sweden). Gentamycin
sulfate (Sigma G3632, 100 mg) and the emulsifiers Span
80 (Sigma, 85548, 500 mL) and Tween 80 (Sigma,
P1754, 500 mL) were purchased from Sigma-Aldrich
Co., Ltd, (Shanghai, China). Two types of bacteria
(Escherichia coli NCTC 12923 and Staphylococcus aur-
eus ATCC 25923) were obtained from the China Center
for Type Culture Collection (CCTCC, Wuhan, China).
Two cell lines (A549, a human lung carcinoma cell line,
CCL-185, and HepG2, a human hepatocellular liver car-
cinoma cell line, HB-8065) were purchased from the
American Type Culture Collection (ATCC, USA). Re-
agents for cell culture and assays were of analytical
grade, as follows: HEPES (N-2-hydroxyethylpiperazine-
N-2-ethanesulfonic acid), L-glutamine, penicillin,
streptomycin, sodium pyruvate, glucose and 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(Sigma, USA); RPMI-1640 (Roswell Park Memorial Insti-
tute medium, Gibco and Hyclone laboratories, USA);
Ham’s/F12 (Nutrient mixture F-12), DMEM (Dulbecco’s
Modified Eagle’s Medium) and FBS (fetal bovine serum,
Hyclone Laboratories, USA). A Bruker AV-300 high-
performance digital NMR spectrometer, TMS internal
standard, Thermo Scientific Multiskan GO enzyme-
labeled instrument (200–1000 nm), and Merck HPTLC
plate, Silica gel 60 were all used in this study.
Extraction, isolation and purification
GBL and MBL air-dried in the shade were pulverized
(1 kg each) and extracted three times with a total of 3 L
of absolute alcohol for 12 h at 75 °C; the samples were
concentrated to yield extracts (220 g from GBL; 185 g
from MBL), which were then mixed with 1 L 50 %
NaOH-water solution for 2 h at 85 °C. The hydrolysates
were extracted three times with 1 L of petroleum ether
(b.p. 90–120 °C). The solvents were evaporated under
vacuum to yield total non-saponifiable lipid extracts
(42 g from GBL; 25 g from MBL), which were each dis-
solved in a solvent mixture (acetone : methanol = 85:15,
v/v) for a solid : liquid ratio of 1:6–1:8 (g/mL) and then
stored for 2 h at −20 °C. The dissolved material was con-
centrated to yield products in the form of a red oil (from
GBL) and a brown oil (from MBL). The red and brown
oils were fractionated by molecular distillation at a feed
temperature of 60 °C, distillation temperature of 280 °C,
feed flow rate of 180 mL/h, scraper rate of 300 rpm, and
operating pressure of 0.1–0.5 Pa to yield heavy distillates
in the form of a dark-red oil (26 g from GBL) and a
dark-brown oil (14 g from MBL). GBP and MBP were
further purified from a portion of the heavy distillates by
flash column chromatography (Merck, Kiesel gel 60;
0.063–0.2 mm particle size; 4 × 60 cm) using petroleum
ether (b.p. 60–90 °C) (5 × 150 mL) and 1 %, 2 %, 3 %,
and 4%ethyl ether/petroleum ether (5 × 250 mL) as elu-
ents. GBP (1.3 g) and MBP (1.1 g) were obtained from
the petroleum/ethyl ether (97 %:3 %, v/v, GBP; 96 %:4 %,
v/v, MBP) portion [1].
Synthesis methods
GPH and MPH
Diethyl azodicarboxylate (0.14 g, 0.80 mmol) was added
with stirring at 30 °C (Ar) to a solution of GBP (0.81 g,
0.70 mmol) or MBP (0.55 g, 0.68 mmol), phthalimide
(0.13 g, 0.88 mmol), and Ph3P (0.24 g, 0.92 mmol) in
5 mL of THF. The reaction mixture was kept for 2 h at
30 °C and concentrated to dryness in vacuo. The residue
was triturated with ether, and the insoluble material was
filtered out. The filtrate was concentrated in vacuo, and
the residue (1.0 g from GBP; 0.8 g from MBP) was chro-
matographed on 35 g of SiO2 in ether-hexane (1:4, v/v)
to yield 0.59 g (68 %) of GPH and 0.45 g (70 %) of MPH
as the same light-yellow oil with an Rf of 0.5–0.55
(ether-hexane, 1:4).
GAM and MAM
A solution of GPH (0.38 g, 0.32 mmol) or MPH (0.30 g,
0.33 mmol) and N2H4•H2O (0.18 g, 3.6 mmol) in a mix-
ture of THF (5 mL) and MeOH (2 mL) was heated for
3 h at 50 °C (Ar) and diluted with ether. The solution
was washed with a saturated solution of NaHCO3 and
water. The organic layer was dried with Na2SO4, and the
solvent was evaporated in vacuo. The residue (0.31 g
from GBP; 0.25 g from MBP) was chromatographed on
30 g of Al2O3. A chloroform-methanol gradient elution
(up to 5 % methanol) yielded 0.18 g (54 %) of GAM and
0.13 g (53 %) of MAM as the same light-yellow oil with
an Rf of 0.65–0.68 (CHCl3: MeOH:H2O, 45:15:1, v/v).
GAS and MAS
Triethylamine (0.13 g, 1.3 mmol) was added to a solu-
tion of GBP (0.27 g, 0.23 mmol) or MBP (0.18 g,
0.22 mmol) in dichloromethane (5 mL). One hundred
microliters of a 10 % solution of POCl3 (20 μL,
0.22 mmol) in dichloromethane was added to the
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reaction mixture with stirring at −60 °C, and the solu-
tion was stirred at −60 °C for 2 h. A mixture of THF-
H2O (1.05 mL, 20:1) was then added, followed by stir-
ring for 2 h. The solvents were evaporated to dryness.
Heptane (10 mL) was added to the residue, and the solu-
tion was kept at −20 °C over night. The solution was
then filtered through a PTFE filter (0.22 μm, Thermo
Fisher). The combined heptane solutions were concen-
trated and dissolved into the upper layer of the equilib-
rium mixture of n-butanol-water (5 mL), and the
solution was washed with the lower layer of the same
equilibrium mixture (3 × 1 mL). The upper layer was
concentrated, and heptane (1 mL) was added to the resi-
due; the mixture was then extracted with acetonitrile
(6 × 2 mL). The combined acetonitrile extracts were con-
centrated to yield the desired products: a light-yellow oil
containing 0.21 g (75 %) of GAS and 0.15 g (73 %) of
MAS, with an Rf of 0.5–0.55 (CHCl3: MeOH:H2O,
40:10:1, v/v).
GTF and MTF
Trifluoroacetic anhydride (0.11 g, 0.52 mmol) was added
to a solution of GBP (0.55 g, 0.48 mmol) or MBP
(0.38 g, 0.48 mmol) in dichloromethane (10 mL), and
the reaction mixture was stirred at 0 °C for 2 h. The so-
lution was washed with a saturated solution of NaHCO3
and water to neutrality. The organic layer was dried with
Na2SO4, and the solvent was evaporated in vacuo and
concentrated to yield the desired products: a yellow oil
containing 0.51 g (93 %) of GTF and 0.36 g (95 %) of
MAS, with an Rf of 0.75–0.80 (ethyl acetate : petroleum
ether, 10:90, v/v).
GCH and MCH
Chloroacetic anhydride (0.08 g, 0.47 mmol) was added
to a solution of GBP (0.53 g, 0.45 mmol) or MBP
(0.36 g, 0.45 mmol) in dichloromethane (10 mL), and
the reaction mixture was stirred at room temperature
for 2 h. The solution was washed with a saturated solu-
tion of NaHCO3 and water to neutrality. The organic
layer was dried with Na2SO4, and the solvent was evapo-
rated in vacuo and concentrated to yield the desired
products: a yellow oilcontaining0.48 g (91 %) of GCH
and 0.33 g (92 %) of MCH, with an Rf of 0.70–0.75
(ethyl acetate: petroleum ether, 10:90, v/v).
1H NMR data
GPH: 1H NMR (300 MHz, CDCl3 δH); 7.65–7.88 (m,
Ph-H), 5.29 (br-t, =CH-CH2-N), 5.15 (m,=CH), 4.28 (br-
d, N-CH2), 1.93–2.17 (m,-CH2), 1.73 (br-s, α-cis-CH3),
1.69 (br-s, cis-CH3), 1.61 (br-s, trans-CH3).
MPH: 1H NMR (300 MHz, CDCl3 δH); 7.67–7.87 (m,
Ph-H), 5.30 (br-t, =CH-CH2-N), 5.14 (m, =CH), 4.29
(br-d, N-CH2), 1.95–2.20 (m, −CH2), 1.72 (br-s, α-cis-
CH3), 1.70 (br-s, cis-CH3), 1.61 (br-s, trans -CH3).
GAM: 1H NMR (300 MHz, CDCl3 δH); 5.28 (br-t,
=CH-CH2-N), 5.13 (m, =CH), 3.26 (br-d, N-CH2), 1.90–
2.15 (m, −CH2), 1.73 (br-s, α-cis-CH3), 1.71 (br-s, cis-
CH3), 1.60 (br-s, trans-CH3).
MAM: 1H NMR (300 MHz, CDCl3 δH); 5.29 (br-t,
=CH-CH2-N), 5.14 (m, =CH), 3.24 (br-d, N-CH2), 1.92–
2.17 (m, −CH2), 1.72 (br-s, α-cis-CH3), 1.70 (br-s, cis-
CH3), 1.61 (br-s, trans-CH3).
GAS: 1H NMR (300 MHz, CDCl3:CD3OD = 4:1 δH);
5.12 (m, =CH-CH2-N), 4.96 (m, =CH), 3.43 (br-d, trans-
CH2-N), 3.41 (br-d, cis-CH2-N), 3.13 (m, CH3-CH2-N),
1.84–2.01 (m, −CH2), 1.75 (br-s, α-cis-CH3), 1.55 (br-s,
cis-CH3), 1.49 (br-s, trans-CH3), 1.48 (br-s, trans-
(CH3)2C = CH), 1.22 (m, CH3-CH2-N).
MAS: 1H NMR (300 MHz, CDCl3:CD3OD = 4:1 δH);
5.14 (m, =CH-CH2-N), 4.98 (m, =CH), 3.44 (br-d, trans-
CH2-N), 3.42 (br-d, cis-CH2-N), 3.15 (m, CH3-CH2-N),
1.85–2.03 (m, −CH2), 1.75 (br-s, α-cis-CH3), 1.54 (br-s,
cis-CH3), 1.47 (br-s, trans-CH3), 1.46 (br-s, trans-
(CH3)2C = CH), 1.21 (m, CH3-CH2-N).
GTF: 1H NMR (300 MHz, CDCl3 δH); 5.40 (m, =CH-
CH2-O-C =O), 5.10 (m, =CH), 4.78–4.81 (br-d, =CH-
CH2-O-C =O), 2.00–2.02 (m, −CH2), 1.80 (br-s, α-cis-
CH3), 1.67 (br-s, cis-CH3), 1.60 (br-s, trans-CH3), 1.25,
1.43, 1.57 (br-s, trans-(CH3)2C = CH).
MTF: 1H NMR (300 MHz, CDCl3 δH); 5.41 (m, =CH-
CH2-O-C =O), 5.12 (m, =CH), 4.80–4.83 (br-d, =CH-
CH2-O-C =O), 2.01–2.04 (m, −CH2), 1.79 (br-s, α-cis-
CH3), 1.68 (br-s, cis-CH3), 1.60 (br-s, trans-CH3), 1.25,
1.43, 1.57 (br-s, trans-(CH3)2C = CH).
GCH: 1H NMR (300 MHz, CDCl3 δH); 5.38 (m, =CH-
CH2-O-C =O), 5.13 (m, =CH), 4.66–4.68 (br-d, =CH-
CH2-O-C =O), 1.99–2.11 (m, −CH2), 1.77 (br-s, α-cis-
CH3), 1.68 (br-s, cis-CH3), 1.60 (br-s, trans-CH3), 1.26,
1.45, 1.59 (br-s, trans-(CH3)2C = CH).
MCH: 1H NMR (300 MHz, CDCl3 δH); 5.39 (m, =CH-
CH2-O-C =O), 5.14 (m, =CH), 4.68–4.70 (br-d, =CH-
CH2-O-C =O), 2.00–2.12 (m, −CH2), 1.75 (br-s, α-cis-
CH3), 1.70 (br-s, cis-CH3), 1.60 (br-s, trans-CH3), 1.26,
1.44, 1.58 (br-s, trans-(CH3)2C = CH).
Determination of antibacterial activity
Escherichia coli and Staphylococcus aureus antibacterial
tests were carried out using Oxford cup assays [27]. All
ten polyprenol derivatives (GPH, MPH, GAM, MAM,
GAS, MAS, GTF, MTF, GCH and MCH), GBP and MBP
were diluted to 500 μg/mL, and the resulting solutions
were added to Oxford cups, which were placed at equal
distances on the agar surface. The zone of inhibition for
each concentration was measured after 24 h of incuba-
tion at 37 °C. The same procedure was repeated in tripli-
cate. Gentamycin sulfate (GS) was used as a positive
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control, and the test samples were prepared as a microe-
mulsion (Span 80 : Tween 80 = 0.514:0.486, wt/wt, HLB
value = 9.5) using the inverse phase emulsification (EIP)
method. A blank microemulsion (only water with the
emulsifiers) was used as the negative control. After 24 h
of incubation, the diameter of the inhibition halos was
observed (measured in mm including disc size). All tests
were performed in triplicate, and the observed values of
the inhibition halos are expressed as mean values with
standard error of the mean (SEM).
Determination of the minimum inhibitory concentration
(MIC)
The MIC values were determined using the broth dilu-
tion method at seven sample concentrations obtained
via serial dilution (250, 125, 62.5, 31.3, 15.6, 7.8, 3.9 μg/
mL). Solutions showing no visible cell growth were sub-
cultured and incubated at 37 °C.
Time-killing curves of E. coli and S. aureus treated with
GAS and MAS at different concentration
Time-killing curve [28] studies for E. coli and S. aureus
were conducted in duplicate on separate days using GAS
and MAS at different concentration (0.5, 1 and 2 times
the MIC). An overnight culture of the isolate was diluted
30-fold with prewarmed Ca-MHB and incubated at 37 °
C until it reached late-log-phase growth. The bacterial
suspension was diluted with Ca-MHB based on the ab-
sorbance at 630 nm; the concentration of the bacterial
suspension in each flask was approximately 109 CFU/
mL. The experiment was conducted for 24 h in a shaker
water bath set at 37 °C. A sample was taken every 2 h
for the first 12 h, every 6 h from 12 to 24 h, and every
12 h from 24 to 48 h. Total bacterial populations were
quantified by spiral plating 10-fold serial dilutions of the
samples (50 μL) onto MHA plates. The plates were incu-
bated in a humidified incubator (37 °C) for 18 to 24 h,
and the bacterial density for each sample was deter-
mined using a CASBA-4 colony scanner and software.
Cell culture and treatment of MAS
The human epithelial cell line A549 was grown in
Ham’s/F12 medium containing 2 mmol/L L-glutamine
supplemented with 100 U/mL penicillin, streptomycin
and 10 % fetal bovine serum at 5 % CO2 and 37 °C. The
human hepatic cell line HepG2 was grown in Dulbecco’s
modified Eagle’s medium (DMEM). Test samples were
prepared as microemulsions (Span 80: Tween 80 =
0.514:0.486, wt/wt, HLB value = 9.5) using the inverse-
phase emulsification (EIP) method. A blank microemul-
sion (only water with emulsifiers) served as the negative
control. The assays were performed in triplicate using
etoposide (EP) as the reference drug. All samples,
controls and solutions were filter sterilized (sterile
0.22 μm filter, Millex®).
Cell viability assay
Cell viability (MTT assay) toward the two cell lines
(A549 and HepG2) was evaluated using a modified
method [29]. In brief, cell lines were suspended in
RPMI-1640 containing 10 % FBS, plated in a 96-well
plate at 1 × 104cells (100 μL) per well, and incubated at
37 °C in a humidified atmosphere (95 % air, 5 % CO2).
After 24 h, an additional aliquot of medium (100 μL)
containing the test compound and vehicle was added to
a final concentration of 50 g/mL with 0.2 % DMSO and
further incubated for 3 days. The cells were subsequently
fixed with 95 % EtOH, stained with crystal violet solu-
tion and lysed with a solution of 0.1 mol/L HCl in
MeOH, after which the absorbance was measured at
550 nm. The A549 and HepG2 cells were stained with
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide). IC50 values were determined as the con-
centrations of drug or sample required to achieve 50 %
cell growth inhibition. To examine the morphology of
derivative treated tumor cells, A549 and HepG2 cells
were preseeded on the coverslip at a density of 2 × 104
cells/mL for 24 h at 37 °C in a 5 % CO2 atm. The deriva-
tive solution was then added, with the high and low con-
centration, and incubated for a further 24 h. The cells
were fixed with 1 % paraformaldehyde (PFA) in PBS and
then treated and observed as described above. The data
were expressed as the percentage of viable cells com-
pared to the survival of the control group (untreated
cells as controls of 100 % viability). Relative inhibition
ratio (R%) was calculated according to formula (1). The
data were expressed as the mean ± SD of three individual
measurements.





Comet assay was performed as described with some spe-
cific modifications according to previous reports (Ali et
al., 2010). Approximately 7 × 104 cells/well were seeded
in a 12-well plate. After 24 h of seeding, cells were
treated with different concentrations of MAS for 24 h.
After the treatments with samples, the cells were trypsi-
nized and re-suspended in DMEM added with 10 % FBS
and the cell suspension was centrifuged at 2 500 g
(1000 rpm) for 5 min at 4 °C. The cell pellet was sus-
pended in ice-chilled phosphate buffer saline for comet
assay. Thereafter, 15 μL of cell suspension (approxi-
mately 2 × 104 cells) was mixed with 85 μL of 0.5 % low
melting-point agarose and it was layered on the end of a
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plain glass slide, pre-coated with a layer of 200 μL 1 %
normal agarose. Subsequently, it was covered with a
third layer of 100 μL 0.5 % low melting-point agarose.
Then, the slides were immersed in the lysis solution
(2.5 mol/L NaCl, 0.1 mol/L Na2EDTA and 0.01 mol/L
Tris with 1 % Triton X-100 and 10 % DMSO, pH 10) for
12 h at 4 °C. The slides were immersed into a cold elec-
trophoresis solution (0.3 mol/L NaOH, 0.001 mol/L
Na2EDTA and 0.2 % DMSO, pH ≥ 13) for 20 min at 4 °
C. Electrophoresis was carried out at 15 V for 20 min at
4 °C. The slides were neutralized with 0.4 mol/L tris buf-
fer (pH 7.5) and stained with ethidium bromide (20 μg/
mL, 75 μL/slide). The slides were stored at 4 °C until
scoring. Slides were processed for analysis at 400 ×mag-
nification using an image analysis system (Comet assay
IV, Kinetic Imaging) attached to a fluorescent micro-
scope (Nikon Eclipse E200). An undamaged cell resem-
bles an intact nucleus without a tail while a damaged
cell has the appearance of a comet. Te percentage of
DNA in the tail (% DNA tail) and tail moment (arbitrary
units) were measured as comet parameters. Images from
100 random cells (50 from each replicate slide) were an-
alyzed for each experiment. All the values were obtained
from the mean ± standard error (SEM) of 2 independent
experiments: in total 200 cells for each concentration.
The statistical analysis was performed using SPSS (ver-
sion 12.0). All data were presented as arithmetic mean ±
standard error. Student’s t-test was selected for the stat-
istical approach and it was used to evaluate the signif-
cance of the difference in DNA damage between the
control and treated cells. Results were considered statis-
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